Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Global HealthASX:GLH 3-Year EBITDA Growth Rate is 24.30% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 524 Healthcare Providers & Services companies, Global Health ranks better than 71.56% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 24.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Global Health was 78.80% per year. The lowest was -217.50% per year. And the median was -10.50% per year.
Global Health (ASX:GLH) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Global Health 3-Year EBITDA Growth Rate Related Terms
ASX:GLH vs VEEV, BTSG, HQY: 3-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, Global Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Health 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Health's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Global Health's 3-Year EBITDA Growth Rate falls into.
Global Health 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 24.30% mean?
Global Health (ASX:GLH) has a 3-Year EBITDA Growth Rate of 24.30% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Global Health and its competitors. According to the industry distribution chart, Global Health ranks #149 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 28.4%.
Is Global Health's 3-Year EBITDA Growth Rate too high?
Global Health's current 3-Year EBITDA Growth Rate is 24.30%. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.25. Global Health's value of 24.30% is 137.1% above this industry median. Based on the distribution chart, Global Health ranks #149 out of 524 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Global Health's 3-Year EBITDA Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Global Health ranks #149 out of 524 companies for 3-Year EBITDA Growth Rate. This puts Global Health in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.25. Global Health's value of 24.30% is 137.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.25, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Global Health's current 3-Year EBITDA Growth Rate of 24.30% is 137.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Global Health and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Health's current 3-Year EBITDA Growth Rate is 24.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (ASX:GLH) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.11, compared to a current price of A$0.07 — trading 40.9% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 24.30% and 137.1% above the Healthcare Providers & Services industry median of 10.25. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Global Health (ASX:GLH), the current 3-Year EBITDA Growth Rate is 24.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Global Health Ltd is engaged in developing, selling, and supporting application software for the healthcare sector in Australia. It operates in a single segment, being the computer technology, software, and services industry. The solutions provided by the company includes Electronic Medical Records, Client Management Systems, Patient Administration Systems, Practice Management Systems, Secure Messaging, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:GLH has been successfully added to your 
